Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
76 Ergebnisse
| MK7C32 |  | Biomarin Pharmaceutical Inc./Faktor/Long [5]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 47,299 | 47,299 | 4,962 | 20,117 % | - | Morgan Stanley | |
| MK802W | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 33,032 | 33,032 | 2,227 | 44,212 % | - | Morgan Stanley | |
| MK94H3 | | Biomarin Pharmaceutical Inc./Faktor/Long [4]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 44,343 | 44,343 | 4,033 | 25,110 % | - | Morgan Stanley | |
| MM0583 | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 40,432 | 43,670 | 3,085 | 26,246 % | - | Morgan Stanley | |
| MM9LYT | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 42,002 | 42,002 | 3,342 | 29,063 % | - | Morgan Stanley | |
| MN8PX3 | | Biomarin Pharmaceutical Inc./Faktor/Long [5]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 47,299 | 47,299 | - | 20,117 % | - | Morgan Stanley | |
| MN96E3 | | Biomarin Pharmaceutical Inc./Faktor/Long [2]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 29,562 | 29,562 | - | 50,073 % | - | Morgan Stanley | |
| MN96LW | | Biomarin Pharmaceutical Inc./Faktor/Short [2]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 88,663 | 88,663 | - | 49,743 % | - | Morgan Stanley | |
| MN9Y3R | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 28,168 | 30,430 | 1,878 | 48,607 % | - | Morgan Stanley | |
| MR0J8L | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 50,624 | 50,624 | - | 14,501 % | - | Morgan Stanley | |
| MR2S02 | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 51,156 | 55,250 | - | 6,688 % | - | Morgan Stanley | |
| MR2S8R | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 55,248 | 55,248 | - | 6,691 % | - | Morgan Stanley | |
| MR3H0Z | | Biomarin Pharmaceutical Inc./Faktor/Short [3]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 78,811 | 78,811 | - | 33,105 % | - | Morgan Stanley | |
| MR3H10 | | Biomarin Pharmaceutical Inc./Faktor/Short [4]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 73,886 | 73,886 | - | 24,786 % | - | Morgan Stanley | |
| MR3H11 | | Biomarin Pharmaceutical Inc./Faktor/Short [5]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 70,930 | 70,930 | - | 19,794 % | - | Morgan Stanley | |
| MR3JM3 | | Biomarin Pharmaceutical Inc./Faktor/Short [3]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 78,811 | 78,811 | - | 33,105 % | - | Morgan Stanley | |
| MR3JM4 | | Biomarin Pharmaceutical Inc./Faktor/Short [4]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 73,886 | 73,886 | - | 24,786 % | - | Morgan Stanley | |
| MR3JM5 | | Biomarin Pharmaceutical Inc./Faktor/Short [5]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 70,930 | 70,930 | - | 19,794 % | - | Morgan Stanley | |
| SJ15EC | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 45,853 | 51,380 | 4,337 | 13,224 % | - | Société Générale | ||
| SJ15F5 | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 81,585 | 71,940 | 2,686 | 21,500 % | - | Société Générale | ||
| SV38A2 | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 100,893 | 100,893 | 1,405 | 70,399 % | - | Société Générale | ||
| SW1WRW | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 44,366 | 44,366 | 3,760 | 25,070 % | - | Société Générale | ||
| SX26A9 | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 71,056 | 71,056 | 4,738 | 20,006 % | - | Société Générale | ||
| SX8C18 | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 70,883 | 62,500 | 5,461 | 5,556 % | - | Société Générale | ||
| SY5D6C | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 90,947 | 90,947 | 1,814 | 53,601 % | - | Société Générale | ||
| SY5QBH | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 80,998 | 80,998 | 2,608 | 36,798 % | - | Société Générale |